Antitrust
RealPage Anticompetitive Cartel Pushes Rents Higher Class Action
This class action alleges that certain lessors who rent out multifamily real estate properties have formed a cartel to take anticompetitive actions in the real estate markets in various locations. The complaint alleges that, with the help of a software platform from RealPage, Inc., a long list of major real estate companies like the Irvine Read more
RealPage Platform Pushes New York Metro Rents Higher Antitrust Class Action
The New York metro area has for a long time been one of the most expensive rental markets in the country. Yet the complaint for this class action alleges that a group of owners and operators of multifamily units in this market, along with software platform RealPage, have conspired to push prices even higher. It Read more
Red Meat Processors Conspiracy to Suppress Workers’ Pay Class Action
Conspiring to hold down wages is illegal, and this antitrust class action alleges that certain red meat processors have been doing exactly that. The defendants include well-known companies like JBS USA Food Company, Tyson Foods, Inc., and Hormel Foods Corp., which together produce around eighty percent of the beef and pork sold to consumers in Read more
Seattle Apartments Price-Fixing Antitrust Class Action
Rents in specific areas of the Seattle, Washington downtown multifamily submarket have been steadily increasing. This antitrust class action alleges that a cartel exists, based on a platform and algorithm from RealPage, Inc., in which the members have agreed to exchange competitive information and raise prices together. The markets involved are the central neighborhoods of Read more
Auto Parts Antitrust Litigation, Round 5 Settlement
This is the fifth and final settlement in a very large antitrust litigation alleging that companies conspired to raise the price of automotive parts, causing consumers to pay more than they should have. This time, the parts include electronic braking systems, hydraulic braking systems, and exhaust systems, made by three company groups: Bosal (Bosal USA, Read more
Opana ER Delayed Generics Antitrust Settlement
Impax Laboratories, Inc. is settling its part of an antitrust class action about an alleged conspiracy between itself and a group of Endo companies, including Endo Health Solutions, Inc., Endo Pharmaceuticals, Inc., and Penwest Pharmaceuticals Co. The complaint alleged that, in June 2010, Impax and Endo entered into a “pay for delay” agreement delaying the Read more
IVF Connecticut Antitrust Settlement
This $2.85 million settlement resolves a class action against four assisted reproductive technology (ART) companies: Women’s Health USA, Inc., In Vitro Services, LLC, Center for Advanced Reproductive Services, PC (CARS), and Reproductive Medicine Associates of Connecticut (RMACT). The complaint alleged that the four conspired to fix or raise prices and allocate geographic markets for ART Read more
Syngenta, Corteva “Loyalty Programs” Restrict Competition Class Action
This antitrust class action bring suit against Syngenta Crop Protection AG, Syngenta Corporation, Syngenta Crop Protection, LLC, and Corteva, Inc., alleging that they have instituted “loyalty programs” for distributors of their pesticides containing certain ingredients. The complaint alleges that the real purpose and effect of these loyalty programs is to restrict the sale of competing Read more
Remicade Antitrust Settlement
Johnson & Johnson and Janssen Biotech, Inc. are putting up $25 million to settle an antitrust class action centering on anticompetitive actions they allegedly took to protect their drug Remicade (infliximab) from competition. The complaint alleged the companies violated federal and state antitrust laws and consumer protection laws by attempting to keep new entrants out Read more
Syngenta, Corteva Anticompetitive “Loyalty Programs” Class Action
The pesticide industry is similar to the pharmaceutical industry in a number of ways, says the complaint for this class action: Both rely on patent protections, both have safety requirements, and in both, generics enter the market after patents have expired. But the complaint brings suit against pesticide companies Syngenta Crop Protection AG, Syngenta Corporation, Read more
